Market Size (2015)
2015
$6.27B
Healthcare
Facial Injectors Market
By Segment, By Region, And Segment Forecasts, 2015 – 2023
Vertical: HealthcareBase Year: 201711 Sections
Executive Summary
Facial Injectors Market — Snapshot
Projected (2023)
2023
$14.57B
CAGR (2015–2023)
11.1%
11.1%Key Players
110+
Facial injectors are drugs used for facial rejuvenation, treating scars, lip augmentation, for the correction of perioral rhytids, cheek augmentation, and other facial improvements. The growing demand for facial aesthetic treatments and technological advancements has led to the growth of the facial injectors market in recent years. Factors such as adverse effects of pollution on the face and increasing acceptance of soft tissue fillers contribute to the growth of the market. In addition to this, the increasing demand for dermal filler techniques in the Asian region is expected to fuel the growth of the market. However, complications during surgeries, the black market, and side-effects connected with facial injectors are likely to restrain the market growth over the forecast period.
The global facial injectors market is growing at a rapid pace. The global facial injectors market is expected to reach USD 14571.47 million by 2023 from USD 7740.16 million in 2017 and is expected to register a CAGR of 11.12% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 44.0% share, followed by Europe and Asia-Pacific with shares of 32% and 17.8%, respectively.
The market has been segmented based on type, application, and end-user.
The global facial injectors market on the basis of type has been segmented into dermal fillers/injector implants and anti-aging/anti-wrinkle injections. On the basis of type, dermal fillers/injector implants accounted for the largest market share of 53% in 2017, with a market value of USD 4104.84 million, which is projected to register a CAGR of 11.61% during the forecast period. The anti-aging/anti-wrinkle injections segment accounted for a market share of 47% in 2017, with a market value of USD 3635.32 million, which is projected to register a CAGR of 10.55% during the forecast period.
The global facial injectors market on the basis of application has been segmented into facial line correction treatment, face-lift, and lip treatments. On the basis of application, the facial line correction treatment accounted for the largest market share of 45.5% in 2017, with a market value of USD 3519.13 million, which is projected to register a CAGR of 10.43% during the forecast period. The face-lift segment accounted for a market share of 36.5% in 2017, with a market value of USD 2824.16 million, which is projected to register a CAGR of 11.84% during the forecast period. The lip treatments segment accounted for a market share of 12.1% in 2017, with a market value of USD 939.68 million, which is projected to register a CAGR of 11.40% during the forecast period. Other segments accounted for a market share of 5.9% in 2017, with a market value of USD 457.18 million.
The market based on end-user has been segmented into dermatology clinics and cosmetic centers, hospitals, and others. Based on end-user, dermatology clinics and cosmetic centers accounted for the largest market share of 42.4% in 2017, with a market value of USD 3279.65 million, which is projected to register a CAGR of 10.78% over the assessment period. The hospitals segment accounted for a market share of 39.1% in 2017, with a market value of USD 3026.78 million, which is projected to register a CAGR of 11.45% over the assessment period. Other segments accounted for a market share of 18.5% in 2017, with a market value of USD 1433.72 million.
Key Insight
The Facial Injectors Market market is projected to grow at a CAGR of 11.1% from 2015 to 2023.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Asia Pacific, Americas, Europe, Middle East and Africa.
- Market Segmentation: The market is analyzed across 2 segments: Dermal Fillers Injectable Implants, Anti-Aging Anti-Wrinkle Injections. Forecasts are provided for each segment from 2015 to 2023.
- Competitive Landscape: 110 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Facial Injectors Market — Growth Trajectory
Facial injectors are injectors filled with drugs that help to improve or correct facial flaws, scars, lips, etc. Owing to the rising demand for facial aesthetic treatments and technological advancements, the growth of the facial injectors market has increased significantly. Facial injectors majorly consist of drugs such as hyaluronic acid or botulinum toxin A. People are able to enhance their beauty and minimize or eliminate the flaws on the face using facial injectors. The increasing adverse effects of pollution on the face and rising acceptance of soft tissue fillers have led to the rise in the demand for facial injectors in recent years. Additionally, the increasing demand for dermal filler techniques is likely to contribute to the growth of the market over the assessment period.
Facial Injectors Market — Growth Trajectory
Dermal Fillers Injectable Implants
Anti-Aging Anti-Wrinkle Injections
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Type Type is broken down into: Anti-Aging Anti-Wrinkle Injections, Dermal Fillers Injectable Implants.
- Application Application is broken down into: Facial Line Correction Treatment, Face-Lift, Lip Treatments, Others.
- End-User End-User is broken down into: Dermatology Clinics & Cosmetic Centers, Hospitals, End-User_Others.
Geographic Analysis
Regional market breakdown
- Asia Pacific Asia Pacific market size reached $1.10B in 2015 and is projected to reach $2.72B by 2023, growing at a CAGR of 12.0%.
- Americas Americas market size reached $2.75B in 2015 and is projected to reach $6.34B by 2023, growing at a CAGR of 11.0%.
- Europe Europe market size reached $1.99B in 2015 and is projected to reach $4.76B by 2023, growing at a CAGR of 11.5%.
- Middle East and Africa Middle East and Africa market size reached $435.53M in 2015 and is projected to reach $753.70M by 2023, growing at a CAGR of 7.1%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Facial Injectors Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Research Process
Historical data (2015–2017) and forecast period (2017–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Facial Injectors Market — Competitive Analysis
Bargaining Power of Suppliers
The suppliers in the global facial injectors industry are the developers and manufacturers of facial injectors or dermal fillers. There is a high number of suppliers in the global facial injectors market thus leading to a high amount of bargaining power in the market. Switching cost of these suppliers is also high as suppliers tend to enter into long-term associations with the aesthetics manufacturers. However, the North American countries and European countries are consisting of a large number of suppliers which offer these facial injectors products at a relatively less price. Due to this reason of high bargaining power of suppliers the profit potential of the global facial injectors industry is reduced.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global facial injectors Market. The market has a large number of buyers comprising of various facial injectors manufacturing companies. The buyers of facial injectors globally are moderately inclined towards facial injectors manufacturers. Moreover, the buyers can exert moderate pressure on the manufacturers as they already provide high-quality products and services. Hence with the high level of products and services provided by the facial injector’s manufacturers the bargaining power of suppliers tend to be moderate.
Threat of New Entrants
Threat of new entrants is medium in the global facial injectors market. Any manufacturing company trying to enter the market is required to accept or abide by the mandatory regulatory standards. The facial injectors market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for newcomers. However, the cost involved in R&D is comparatively high which does not comfort the new entrants to enter the market easily.
Threat of Substitutes
The threat of substitutes in the global facial injectors market is low with the only substitute is in the form of other types of facial injectors or dermal fillers available in the facial injectors market. Buyer propensity to substitute is less due to the low availability of substitutes in this market. In addition, the high degree of switching cost minimizes the threat of substitutes.
Intense Rivalry
The degree of competition in the global facial injectors market is moderately high. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. facial injectors manufacturing companies are trying to develop less expensive products in order to make these products more affordable in developing markets. To overcome the competition, players are engaged in developing a process to lower their manufacturing cost. Moreover, the players are also developing advanced products for differentiating their brand from their competitors.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Facial Injectors Market.
Regional Market Size (USD Mn)
Market estimates by geography (2023)
USD Mn
InsightAmericas leads with $6.34B by 2023, while Asia Pacific is projected to grow fastest at a 12.0% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $1.10B | $1.73B | $2.72B | 12.0% | 19% |
| Americas | $2.75B | $4.22B | $6.34B | 11.0% | 44% |
| Europe | $1.99B | $3.08B | $4.76B | 11.5% | 33% |
| Middle East and Africa | $435.53M | $531.22M | $753.70M | 7.1% | 5% |
| Total | $6.27B | $9.56B | $14.57B | 11.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2023)
Dermal Fillers Injectable Implants
Anti-Aging Anti-Wrinkle Injections
02182436565478729
Segment Market Share
- Dermal Fillers Injectable Implants54%
- Anti-Aging Anti-Wrinkle Injections46%
Total Market Size
$14.57B
Market by Segment (2023)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Dermal Fillers Injectable Implants | $7.93B | 11.1% | 66% |
| Anti-Aging Anti-Wrinkle Injections | $6.64B | 11.1% | 66% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Facial Injectors Market — Key Findings
Analytical insights on Facial Injectors Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Facial Injectors Market market is projected to reach $14.57B by 2023, growing at 11.1% CAGR. The Dermal Fillers Injectable Implants segment holds the largest share.
Market Dynamics
The global facial injectors market is growing on the preliminary backgrounds of various factors. The growth of the facial injectors market is mainly driven by the growing demand for facial aesthetic treatments, technological advancements, effects of pollution, increasing acceptance of soft tissue fillers, and growing demand for dermal filler techniques from the Asian region. Patient groups are attracted to minimally invasive procedures to treat a variety of facial aesthetic imperfections including acne, scars, wrinkles, skin discolorations, and unwanted spots. The increasing awareness about the benefits of combination therapies in aesthetic medicines is also leading to its widespread acceptance among the population of all age groups.
Market Drivers
Facial aesthetic treatments are used for the treatment of skin problems such as acne, scars, wrinkles, skin discolorations, and unwanted spots. Increasing number of populations suffering from aesthetic imperfections is contributing to the rising demand for facial aesthetics treatment. The increasing demand for facial aesthetic procedures is a major factor accelerating the growth of the market. For instance, according to the article published by the Royal Australian College of General Practitioners in 2017, 90%of the Australian adolescent population is suffering from common acne or acne vulgaris
Market Opportunities
The global population is majorly focusing towards minimally invasive procedures to treat a variety of medical and aesthetic imperfections such as scars, wrinkles, skin discolorations, unwanted spots, excess fat, spider veins etc. The increasing awareness about the benefits of combination therapies in aesthetic medicines is leading to its widespread acceptance among the population of all age groups.
As indicated by the World Population Report, 2015 published by the United Nations, the worldwide population is aging at a rate of 1.18% per annum. Furthermore, the increase in demand for less painful and minimum invasive procedures is expected to drive the growth of the market the during forecast period. On the other hand, the increasing interest in clinically-proven evidenced ingredients is boosting the demand for facial aesthetic treatments. According to the American Society of Plastic Surgeons (ASPS), 17.5 million cosmetic procedures were performed in the US in 2017.
Market Restraints
With every medical procedure, there is a degree of risk associated with the use of facial injectors or dermal fillers. Although serious complications arising from their use is infrequent. Unwanted adverse events do occur with all soft tissue filling compounds. However, their true prevalence is unknown. These adverse events may be injection related, technique related, or (rarely) may be owing to localized exposure to HA itself, potential residual purification solvents, or trace presence of endotoxin
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2023)
Value (USD Mn)
Dermal Fillers Injectable Implants
Anti-Aging Anti-Wrinkle Injections
Companies
Key companies profiled in Facial Injectors Market
Profiles of 110 companies operating in the Facial Injectors Market market, including revenue, employee count, and market positioning where available.
Showing 110 of 110 companies
Galderma S
Galderma S.A.
Healthcare
Company Headquarter: Lausanne, Switzerland Founded: 1981 Workforce: 6000+ Employees Company Working: Galderma S.A.is one of the big names of the pharmaceutical industry in the dermatology segment. Over the past three decades, the key areas of focus for Galderma S.A. are to provide innovative solutions in the field of dermatology, which consists of acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer, and other various fields in skin care. Currently, Galderma is a global leader in dermatology and has strategic partnerships with brands such as Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel, and many other brands.
Revenue$89.0B
Employees6,000
Market CapN/A
Founded1980
United States, North America
Ipsen Phar
Ipsen Pharma
Healthcare
Company Headquarters: Paris, France Founded: 1929 Workforce: ~ 5,400+ Company Working: Ipsen Pharma is a global pharmaceutical company operating in two segments, namely, specialty care and consumer healthcare. The company offers drugs in oncology, endocrinology, neurology, gastroenterology, cognitive disorders, and rare disease areas. In the neuroscience segment, the company provides products for the treatment of cervical dystonia, adult spasticity, blepharospasm, hemifacial spasm, hyperhidrosis, and pediatric lower limb spasticity. Ipsen Pharma operates as a subsidiary of Mayroy S.A. The company has R&D centers and manufacturing sites located in China, France, Ireland, the UK, and the US. Ipsen Pharma is present in more than 115 countries and has a direct presence through corporates offices in around 35 countries across the globe.
Revenue$1.5B
Employees5,400
Market CapN/A
Founded1928
Paris, France
SciVision
SciVision Biotech Inc.
Healthcare
Company Headquarters: Taiwan Founded: 2001 Workforce: ~15 Company Working: SciVision Biotech Inc. is involved in the manufacturing and marketing of hyaluronic acid products in Taiwan. The company operates through the following segments, namely, absorbable adhesion barriers, dermal implants, synovial fluid supplements, intravesical instillations, and skincare products. The company operates through several business areas, such as aesthetics and skincare.
RevenueN/A
Employees15
Market CapN/A
Founded2000
Taiwan
Suneva Med
Suneva Medical
Healthcare
Company Headquarters: California, US Founded: 2009 Workforce: ~104 Company Working: Suneva Medical Inc., is a medical technology company. It is engaged in the manufacturing and distribution of aesthetics and skincare products. The company offers products to treat acne, wrinkles, and skin regeneration. The US, Canada, South Korea, Hong Kong, and Singapore are the major markets covered by Suneva Medical, Inc. In 2017, the company celebrated ten years of its flagship brand, Bellafill. Moreover. The firm's recently enlarged portfolio offers suppliers cutting-edge, scientifically supported products that aim to solve important patient needs safely and effectively.
RevenueN/A
Employees104
Market CapN/A
Founded2008
California, US
Sinclair P
Sinclair Pharma
Healthcare
Company Headquarters: London, UK Founded: 1971 Workforce: 1,000 Company Working: Sinclair Pharma is a global healthcare company engaged in the development, manufacture, and distribution of pharmaceutical products. Other medical offerings of the company include aesthetics and cosmetic products. It has a portfolio of differentiated complementary aesthetics technologies with a focus on collagen stimulation. The company constitutes a huge network of international distributors throughout the world. Sinclair Pharma operates as a subsidiary of Huadong Medicine Co., Ltd.(China). The company has a strong presence in Europe, as well as the US, Brazil, and South Korea
Revenue$5.4B
Employees1,000
Market CapN/A
Founded1970
London, UK
Allergan
Allergan
Healthcare
Company Headquarters: Dublin, Ireland Founded: 2013 Workforce: ~16,900 Company Working: Allergan is a leading global pharmaceutical company. The company is engaged in the manufacturing and commercialization of hyaluronic acid for medical products, devices, biologics, and surgical products for patients across the world. It operates through three business segments, namely US Specialized Therapeutics, US General Medicine, and International. The company sells its products primarily to the retailers and distributors including food store chains and national retail drug. The prime customers are hospitals, clinics, and government agencies as well as managed healthcare providers, such as health maintenance organizations and other institutions. The company has operations in 100 countries. The US and Canada account for around 10% of the company’s revenue. The three prominent customers of the company are McKesson Corporation, which accounted for around 25% of the sales revenue; Cardinal Health, Inc with 23%; and AmerisourceBergen Corporation with 22% in 2018. In addition, the company has development and manufacturing centers of raw materials, intermediate ingredients, and active pharmaceutical ingredients. Its manufacturing plants are located in Ireland, the US, Brazil, Belgium, France, and Costa Rica.
Revenue$14.6B
Employees16,900
Market CapN/A
Founded2012
Dublin, Ireland
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Facial Injectors Market
Starting from
$4,950